• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    CTI BioPharma Corp. (CTIC)

    -NasdaqCM
    2.44 Up 0.01(0.41%) Dec 19, 4:00PM EST
    |After Hours : 2.48 Up 0.04 (1.64%) Dec 19, 5:28PM EST
    Add to Portfolio
    Prev Close:2.43
    Open:2.36
    Bid:N/A
    Ask:3.61 x 400
    1y Target Est:5.50
    Beta:1.64
    Earnings Date:Mar 2 - Mar 6 (Est.)
    Day's Range:2.36 - 2.51
    52wk Range:1.75 - 4.25
    Volume:4,212,385
    Avg Vol (3m):1,449,100
    Market Cap:354.14M
    P/E (ttm):N/A
    EPS (ttm):-0.30
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CTIC

    Comparison

    Symbol% ChgMkt Cap
    CTICUp 0.41%354.14M
    BMYUp 0.84%101.68B
    RHHBYDown 6.59%234.22B
    SNYDown 0.90%121.74B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.69
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.59
    Quarterly EPS Est (Dec-14) :-0.18
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CTI BioPharma Corp., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback